NICE has rejected regular NHS funding for Janssen ... other factors. Spravato is approved as an adjunctive therapy administered by a nasal spray and is based on esketamine, a form of the drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback